Mohammad Razaq is an Oncology physician affiliated with University of Oklahoma Health Sciences Center. OpenAlex indexes 41 publications with 1,634 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
1 company with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
38.5%Aromatase Inhibitor19.6%Letrozole78%Anastrozole22%Part D<11 patientsKinase inhibitor8%Ibrance32%Verzenio25%Cabometyx25%Jakafi19%Part D<11 patients+ 4 more classes in this area
Metabolism & gastrointestinal
22.9%Corticosteroid7.8%Prednisone100%Part D≥25 patientsSerotonin-3 Receptor Antagonist6.7%Ondansetron Odt100%Part D≥37 patients+ 3 more classes in this area
Nervous system
8.1%Opioid Agonist2.6%Oxycodone-Acetaminophen100%Part D<11 patientsGabapentinoids2%Gabapentin100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Ira Targoff, MD
University of Oklahoma Health Sciences Center
Steven Chernausek, MD
University of Oklahoma Health Sciences Center
Udho Thadani, MD
University of Oklahoma Health Sciences Center
Michael Bronze, MD
University of Oklahoma Health Sciences Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”